Key result
Anticoagulation and GDMT drive clinical improvement in a case of ADHF with laminated LV thrombus.
Why the study?
Optimal pharmacotherapeutic management of left ventricular thrombus remains uncertain, particularly when thrombus morphology suggests lower embolic potential.
Case Report (n=1)
Systemic anticoagulation combined with GDMT and diuresis can be a safe, noninvasive treatment strategy for laminated LV thrombus in acute decompensated heart failure.
Answers are grounded in this paper and cite their sources.
Supports noninvasive anticoagulation with GDMT in select stable ADHF cases with laminated LV thrombus; leaves open need for prospective trials to guide practice.
Left ventricular (LV) thrombus is a known complication of severe systolic dysfunction and is associated with an increased risk of systemic embolization. Optimal pharmacotherapeutic management remains an area of clinical uncertainty, particularly when thrombus morphology suggests lower embolic potential. A 56-year-old man with multiple cardiovascular risk factors presented with progressive dyspnea, anasarca, and hypoxic respiratory failure. Cardiac imaging demonstrated severe biventricular dysfunction (ejection fraction <20%) and a large, laminated, nonmobile apical LV thrombus. Concurrent findings included congestive hepatopathy with ascites and a small pulmonary embolism. Based on thrombus morphology and clinical stability, systemic anticoagulation was initiated without invasive intervention. The patient improved with aggressive diuresis, guideline-directed medical therapy for heart failure, and therapeutic anticoagulation. This case highlights pharmacotherapeutic considerations in the management of laminated LV thrombus, including the role of thrombus morphology in risk stratification, anticoagulant selection, and timing of therapy initiation. Early recognition and coordinated interdisciplinary management can support safe, noninvasive treatment strategies in complex heart failure presentations. In addition, this case highlights the importance of collaborative practice and pharmacist-guided anticoagulation strategies.
No takes yet. Share an insight, caveat, or question.
Acosta et al. (2026) conducted a case report in Acute decompensated heart failure with laminated left ventricular thrombus (n=1). Systemic anticoagulation was evaluated on Clinical improvement. Systemic anticoagulation and guideline-directed medical therapy led to clinical improvement in a 56-year-old man with acute decompensated heart failure and a laminated left ventricular thrombus.
Synapse has enriched 10 related papers. Consider them for comparative context: